The major virulence factor of Streptococcus pyogenes, the M protein, is positively regulated at the transcriptional level by mry in the M type 6 strain studied. We show here that in two S. pyogenes strains isolated from cases of toxic-shock-like syndrome, a type Ml strain and a type M3 strain, an mry-like gene is also required for resistance to phagocytosis.
The group A streptococcus, Streptococcus pyogenes, is a human pathogen that causes serious diseases. Primary suppurative infections, including pharyngitis and impetigo, may lead (respectively) to the more serious sequelae of rheumatic heart disease and acute glomerulonephritis. In addition, myositis and fasciitis result when this organism invades tissue. In the last 5 years, S. pyogenes has also been recognized as the causative agent of a severe, toxic-shocklike syndrome (TSLS) (1) . TSLS is defined by isolation of S. pyogenes from normally sterile body sites as well as multisystem organ involvement, including hypotension, thrombocytopenia, respiratory distress, and hepatic and renal involvement (20) . In addition, a generalized rash is often observed, and soft tissue necrosis may occur as well. The recent recognition of the often fatal TSLS and the observation of recurrence of rheumatic heart disease have focused attention on their causative agent, S. pyogenes.
The M protein present on the surface of virulent S. pyogenes strains protects them from phagocytosis by polymorphonuclear leukocytes (11) . M proteins, which are dimeric, alpha-helical coiled-coil molecules attached to the streptococcal surface at their carboxy termini, are thus considered to be the most important virulence factors of this organism. Some anti-M protein antibodies produced after infection with S. pyogenes are opsonic and, therefore, protect against future infections with the same organism. This has led to the idea that a vaccine against S. pyogenes might be based on the M molecule. However, over 80 different serological types of M protein have been defined, and opsonic antibodies tend to be type specific. Although the carboxy-terminal region of the M molecule appears to be highly conserved (9), it is not yet clear whether antibodies to this region of the protein would be protective. Furthermore, some anti-M protein antibodies have been found to react with human tissue, especially that of the heart (4). It therefore seems appropriate to consider other approaches for prevention of streptococcal disease.
In the M6 strain JRS4, expression of M protein requires the presence of a trans-acting positive regulator, mry (3, 12 (8, 14) and that mry might be critical for expression of virulence determinants by these important pathogens. If this is confirmed, mry might be a potential target for antistreptococcal therapy.
The work presented here was designed to begin to determine whether mry-like sequences in strains other than JRS4 and CS64 are functional in regulating expression of M protein and in determining virulence. Because of the concern about the seriousness of streptococcal TSLS, we selected contains a 1-kb XbaI-SstI segment internal to the mry gene (miy, black box), joined to the omega-Km2 element (Q1Km, stippled box) carrying signals for termination of transcription and translation (12) . The vector pJRS233 (thin line) contains two replication origins, one from pSC101
and one from a temperature-sensitive replication mutant derived from pGK12, a natural gram-positive-to gram-negative-bacterium shuttle plasmid; it also contains a gene conferring resistance to erythromycin (Em, checkered box [13] and kanamycin (500 p,g/ml) were passed on Todd-Hewitt yeast plates containing erythromycin (to select for the plasmid) at 37°C (to prevent autonomous plasmid replication). Colonies were streak purified, and one derivative from each strain was chosen for further analysis. The derivatives of JRS301 (Ml), JRS333 (M3), and JRS4 (M6) were named JRS403, JRS483, and JRS442, respectively. Confirmation of insertion mutation by Southern blot analysis. The majority of the plasmid DNA used for electroporation was in dimeric (18.4-kb) form (Fig. 1A) , as indicated by agarose gel electrophoresis (data not shown). Therefore, two copies of the plasmid were expected to integrate into the mry gene of the recipient strains. To confirm insertion of this 18.4-kb dimeric plasmid into the mry gene in each strain, Southern blot analyses were performed.
Chromosomal DNA from JRS301, JRS333, JRS403, and JRS483 was digested with the restriction endonuclease PvuII, which does not cut either the miy gene or pJRS1039 (Fig. 1A) , and hybridized with a 1.5-kb fragment containing the entire mty gene. The probe hybridized to a 3.0-kb band from strain JRS301 and a 3.4-kb band from strain JRS333, indicating some heterogeneity in these chromosomal regions of these strains (Fig. 1B, lanes A and C, respectively) . This is consistent with the fact that these two strains conform to different patterns when the region between their mry and emm genes is amplified with specific primers (8) . As expected for recombination of a dimer molecule of pJRS1039 into chromosomal DNA, in each of the two mutant strains, the PvuII fragment homologous to miy was in the largemolecular-size range, around 21.6 kb (Fig. 1B, lanes B and  D) .
HindIII digestion was also used for these analyses. Like PvuII, HindIII does not cleave the mry genes; however, unlike PvuIl, HindIII does cleave pJRS1039 three times, resulting in fragments of 0.4, 1.86, and 6.9 kb (Fig. 1A) . The 6.9-kb fragment contains the internal fragment from the mry gene (Fig. 1C, lane G) . This same HindIlI fragment is also present in all the insertion mutants (Fig. 1C, lanes B, D, and  F) , indicating the presence of two copies of pJRS1039 in the chromosomes of the mutant strains. In the wild-type strain JRS4, the single HindIll band homologous to the mry probe is, as expected, ca. 6.0 kb (3) (Fig. 1A and C, lane E) . This HindIII fragment is about the same size for JRS301 and ca. 6.8 kb for JRS333 (Fig. 1C, lanes A and C, respectively) , again suggesting sequence heterogeneity in this region. If a dimer of pJRS1039 had recombined at the mty locus, the mutant strains should contain three HindIII bands homologous to the mry probe (Fig. 1A) . The Southern blot confirms these predictions (Fig. 1C, lanes B, D, and F) , indicating that the mry-like genes in each strain have been interrupted by integration of the pJRS1039 plasmid dimer.
Western blots (immunoblots). The simplest test of whether the mry insertion mutants no longer produce M protein is Western blot analysis. Although the M3 typing antiserum was not sufficiently specific to allow identification of the M protein from this strain, the specificity of the Ml typing antiserum was adequate for this analysis. A lysin extract (5) of the Ml wild-type strain JRS301 shows the characteristic three-band pattern of an M protein (Fig. 2, lanes 2 and 4) . The smallest of these bands has an apparent molecular mass a Assays were performed as described by Perez-Casal et al. (13) .
of about 52 kDa. (The multiple bands above this band are probably composed of these M protein molecules with an associated cell wall fragment that is released during the lysin extraction procedure [5] .) The extract of the Ml insertion mutant, strain JRS403 (Fig. 2, lanes 1 and 3) For these assays, an extract from the M6 strain JRS4 was included as a positive control. Fibrinogen bound to bands of the size expected (the smallest at about 53 kDa) for the M6 protein from this strain (Fig. 3, lanes 5 and 6) , and no such bands were seen in the M6-deletion derivative JRS145 (Fig.  3, lanes 7 and 8) used as a negative control. The M3 strain JRS333 did not produce fibrinogen-binding protein detectable by this procedure (data not shown). However, in the extract from the Ml strain JRS301, fibrinogen bound to bands with apparent molecular masses of 52, 53, and 54 kDa (Fig. 3, lanes 1 and 2) . These bands correspond in size to those detected by the anti-Mi typing serum in the Western blot. The insertion mutant JRS403 did not bind fibrinogen (Fig. 3, lanes 3 and 4) , confirming the absence of M protein from this organism.
Resistance to phagocytosis. S. pyogenes JRS301, JRS403, JRS333, JRS483, JRS4, and JRS442 were subjected to a 3-h incubation in whole human blood or plasma at 37°C (13) . The three wild-type strains, JRS301 (Ml), JRS333 (M3), and JRS4 (M6), as well as strains derived from them by insertion of the vector pJRS233, multiplied in the presence either of plasma or of whole human blood (Table 1) . This indicates that they resist phagocytosis by human phagocytes. In contrast, although the three mutant strains, JRS403, JRS483, and JRS442, grew in plasma, showing that there were no type-specific antibodies in the blood used, they failed to survive in whole blood.
It therefore appears that in S. pyogenes 
